Related Experiment Video
Updated: Jan 19, 2026

05:00
Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
Published on: April 1, 2019
15.6K
[Intense pulsed light (IPL) as a therapeutic option for Meibomian gland dysfunction]
A Schuh1, S Priglinger2, E M Messmer2
1Augenklinik, Klinikum der Universität München, Campus Innenstadt, Mathildenstr. 8, 80336, München, Deutschland. anna.schuh@med.uni-muenchen.de.
Summary
Intense pulsed light (IPL) therapy offers a safe and effective new treatment for Meibomian gland dysfunction (MGD), a common cause of dry eye disease. Studies show IPL improves both patient-reported symptoms and clinical signs of MGD.
Area of Science:
- Ophthalmology
- Dermatology
Background:
- Meibomian gland dysfunction (MGD) is a prevalent condition contributing to dry eye disease.
- Effective therapeutic options for MGD are continually being sought.
Purpose of the Study:
- To evaluate the efficacy of intense pulsed light (IPL) as a treatment for Meibomian gland dysfunction (MGD).
Main Methods:
- The study involved 2-4 sessions of intense pulsed light (IPL) application to the lower eyelid and temporal lid margin.
- Safety precautions were adhered to during the IPL treatment procedure.
Main Results:
- Intense pulsed light (IPL) treatment demonstrated improvements in subjective patient symptoms.
- Objectively measured clinical parameters associated with Meibomian gland dysfunction (MGD) also showed enhancement.
Conclusions:
- Intense pulsed light (IPL) is a safe and approved therapeutic option for managing Meibomian gland dysfunction (MGD).
- IPL treatment leads to significant improvements in both patient-reported outcomes and clinical findings for MGD.
More Related Videos
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.6K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.6K
Open Angle Glaucoma: Treatment
964
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
964

